This content is machine translated HFpEF 2025 Precision medicine and phenotypes In 2025, heart failure with preserved ejection fraction (HFpEF) is less than ever a single clinical picture – it is an umbrella over many phenotypes with different triggers, pathomechanisms and...…
View Post 6 min This content is machine translated Dapagliflozin for T2D and heart failure Epicardial fat reduced in patients with type 2 diabetes and HF The co-occurrence of heart failure (HF) and diabetes leads to a higher risk of complications, higher mortality and worse outcomes than either disease alone. Studies have shown the importance of...…
View Post 4 min This content is machine translated Journal Club: Drinking restriction in heart failure First large-scale study found no differences Patients with heart failure are often recommended to drink a maximum of 1.5 liters of fluid per day. However, the benefits of this measure have hardly been scientifically proven to...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 4 min This content is machine translated Heart failure Gradually expand drug therapy! Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 3 min This content is machine translated Heart failure in the light of the latest evidence MRAs offer advantages across the entire EF spectrum At the swissESCupdate, cardiology experts summarized important content from this year’s Annual Meeting of the European Society of Cardiology . In the area of heart failure, studies on the use…
View Post 3 min This content is machine translated Metabolic disorders and heart failure Cardiac metabolism in old age: effects and consequences Cardiovascular disease, particularly coronary artery disease (CAD) and heart failure (HF), is common in the ageing population and is one of the leading causes of death worldwide. With age, the…
View Post 5 min This content is machine translated Chronic heart failure Recognize early and initiate intervention The incidence and prevalence of chronic heart failure are positively correlated with age, although there are other risk factors such as obesity, diabetes and hypertension. In addition to the treatment…
View Post 4 min This content is machine translated Type 2 diabetes Cardiovascular optimized therapy up-to-date The current ESC guideline recommends blood glucose-lowering substances with a proven cardiovascular benefit for certain risk groups among type 2 diabetics. In type 2 diabetes (T2D) and atherosclerotic cardiovascular disease…
